Catheter-related bacteremia due to Chryseobacterium indologenes in a bone marrow transplant recipient [2]

Bone Marrow Transplantation

Volumn 37, Issue 4, 2006, Pages 435-436

  Akay, Melhak ^a   Gunduz, E ^a   Gulbas, Z ^a  

^a OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPHOTERICIN B; AZTREONAM; BUSULFAN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; GENTAMICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMIPENEM; MITOXANTRONE; PIPERACILLIN PLUS TAZOBACTAM; TICARCILLIN; TOBRAMYCIN; VANCOMYCIN;

ACUTE KIDNEY FAILURE; ADULT; BACTEREMIA; BACTERIUM ISOLATE; BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; CASE REPORT; CATHETER INFECTION; CHRYSEOBACTERIUM INDOLOGENES; DEATH; FEVER; HEMODIALYSIS; HLA MATCHING; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HUMAN TISSUE; LETTER; MALE; MULTIPLE ORGAN FAILURE; MYCOSIS; MYELODYSPLASTIC SYNDROME; PANCYTOPENIA; PRIORITY JOURNAL; RECIPIENT; REMISSION; SEPTICEMIA; VEIN OCCLUSION;

BACTEREMIA; BONE MARROW TRANSPLANTATION; CATHETERIZATION; CHRYSEOBACTERIUM; FATAL OUTCOME; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED;

EID: 32844463745     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705261     Document Type: Letter

References (10)

1. Chang JC, Hsueh PR, Wu JJ, Ho SW, Hsieh WC, Luh KT. Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods. Antimicrob Agents Chemother 1997; 41: 1301-1306.
2. Hsueh PR, Teng LJ, Yang PC, Ho SW, Hsieh WC, Luh KT. Increasing incidence of nosocomial chryseobacterium indologenes infections in Taiwan. Eur J Clin Microbiol Infect Dis 1997; 16: 568-574.
3. Nulens E, Bussels B, Bols A, Gordts B, Van Landuyt HW. Recurrent bacteremia by chrysebacterium indologenes in an oncology patient with a totally implanted intravascular device. Clin Microbiol Infect 2001; 17: 391-393.
4. Lu PC, Chan JC. Flavobacterium indologenes keratitis. Opthalmologica 1997; 211: 98-100.
5. Green BT, Nolan PE. Cellulitis and bacteremia due to Chryseobacterium indologenes. J Infect 2001; 42: 219-220.
6. Lin JT, Wang WS, Yen CC, Liu JH, Chiou TJ, Yang MH et al. Chryseobacterium indologenes bacteremia in a bone marrow transplant recipient with chronic graft-versus-host disease. Scand J Infect 2003; 35: 882-883.
7. Christakis GB, Perlorentzou SP, Chakliopouloq I. Chryseobacterium indologenes non-catheter related bacteremia in a patient with a solid tumor. J Clin Microbial 2005; 43: 2021-2023.
8. Cascio A, Stassi G, Costa GB, Crisafulli G, Rulli I, Ruggeri C et al. Chryseobacterium indologenes bacteraemia in a diabetic child. J Med Microbiol 2005; 54: 677-680.
9. Hsueh PR, Teng LJ, Ho SW, Hsieh WC, Luh KT. Clinical and microbiological characteristics of Flavobacterium indologenes infections associated with indwelling devices. J Clin Micro 1996; 34: 1908-1913.
10. Kirby JT, Sader HS, Walsh TR, Jones RH. Antimicrobial susceptibility and epidemiology of a worldwide collection of chryseobacterium spp.: Report from the Sentry antimicrobial surveillance program (1997-2001). J Clin Micro 2004; 42: 445-448.